Cargando…
rDNA insulin glargine U300 – a critical appraisal
BACKGROUND: As the first once-daily basal insulin analog, insulin glargine 100 U/mL (Gla-100; Lantus(®)) rapidly evolved into the most commonly prescribed insulin therapy worldwide. However, this insulin has clinical limitations. The approval of new basal insulin analogs in 2015 has already started...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144903/ https://www.ncbi.nlm.nih.gov/pubmed/27980431 http://dx.doi.org/10.2147/DMSO.S87873 |